Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Ruxolitinib | 0.3 | uM | 1 | IL3 | 48.0 | 82 | ||||
N2586 | Tofacitinib | 0.3 | uM | 1 | IL3 | 49.0 | 61 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | IL3 | 40.0 | 50 | ||||
N2586 | 1 | IL3 | 45.5 | 44 | |||||||
0 | IL3 | 57.0 | 67 | ||||||||
0 | IL3 | 42.0 | 52 | ||||||||
RA2159 | TNF-a | 100 | ng/mL | 1 | IL3 | 41.0 | 59 | ||||
RA2159 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 1 | IL3 | 40.0 | 83 | |
RA2159 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL3 | 51.5 | 90 | |
RA2159 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL3 | 46.0 | 75 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL3 | 62.5 | 70 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | IL3 | 41.5 | 64 | |
RA2159 | EO1428 | 1.0 | uM | 1 | IL3 | 45.0 | 71 | ||||
N2586 | TNF-a | 100 | ng/mL | 1 | IL3 | 59.0 | 57 | ||||
N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 1 | IL3 | 52.0 | 47 | |
N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL3 | 46.5 | 42 | |
N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL3 | 46.0 | 75 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 1 | IL3 | 52.5 | 80 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 1 | IL3 | 50.0 | 46 | |
N2586 | EO1428 | 1.0 | uM | 1 | IL3 | 46.0 | 57 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 1 | IL3 | 52.0 | 65 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL3 | 47.0 | 78 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL3 | 55.5 | 70 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL3 | 53.0 | 50 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | IL3 | 49.5 | 54 |